Elements of clinical report Flashcards
(49 cards)
What Genomic variants does it include?
Somatic (potentially actionable)
Somatic (biologically relevant)
Germline (Pathogenic /likely pathogenic)
Also included: Immunotherapy markers, which are?
- TMB
- MSI status
What do they mean?
if a patient is a candidate for immunotherapy or not.
Also included: Treatment implications
- FDA approved therapies, current diagnosis
- FDA approved therapies, other types
- Additional indicators (variants detected in patient sample)
What happens once the report is done?
A lab director signs off on the report so it can be returned to the appropriate physician.
Process of determining if variants detected are pathogenic. VUS or benign
variant analysis
targeted therapies added to the report based on patients unique molecular profile
Therapy application
Immunotherapy markers which are included in the report
TMB and MSI
The first step in this is to filter the raw data from sequencing
Bioinformatics pipeline
Report delivery
Report is uploaded to the portal and provider/care team is notified
How are they notified?
- Fax report
- email-based delivery (no PHI) contains a link to a secure portal
- custodian path labs may opt-in to receive a report via fax.
What is this controlled in?
Salesforce
What does QNS mean?
Quality/Quantity not sufficient
What does ATR stand for?
Additional Tissue Request
Intro to variant classification
- Somatic vs. Germline
What is Genomic testing about?
Detection and Interpretation
What does “Wildtype” mean?
Refers to the non-mutated form of a gene. (The “normal” condition)
What’s an example of this?
If a person is “wild type” they are considered normal across the gene pool and have no mutations present.
What’s the opposite?
Mutation/ alteration/variant allele
What are the 3 main questions variant scientists need to ask?
- ) is there a mutation present?
- ) Does the mutation impact the protein?
- ) Does that impact make a difference clinically? would this need to be shown in the report.
What are the tiers to classify?
Tier I
Tier II
Tier III
Tier IV
Tier I
Variants of strong clinical significance
Tier II
Variants of potential clinical significance
Tier III
Variants of unknown clinical significance